These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 12139296)

  • 1. Prevention of ventricular fibrillation by cilostazol, an oral phosphodiesterase inhibitor, in a patient with Brugada syndrome.
    Tsuchiya T; Ashikaga K; Honda T; Arita M
    J Cardiovasc Electrophysiol; 2002 Jul; 13(7):698-701. PubMed ID: 12139296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Failure of cilostazol in the prevention of ventricular fibrillation in a patient with Brugada syndrome.
    Abud A; Bagattin D; Goyeneche R; Becker C
    J Cardiovasc Electrophysiol; 2006 Feb; 17(2):210-2. PubMed ID: 16533260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination therapy of cilostazol and bepridil suppresses recurrent ventricular fibrillation related to J-wave syndromes.
    Shinohara T; Ebata Y; Ayabe R; Fukui A; Okada N; Yufu K; Nakagawa M; Takahashi N
    Heart Rhythm; 2014 Aug; 11(8):1441-5. PubMed ID: 24813378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful prevention of recurrent ventricular fibrillation by intravenous isoproterenol in a patient with Brugada syndrome.
    Tanaka H; Kinoshita O; Uchikawa S; Kasai H; Nakamura M; Izawa A; Yokoseki O; Kitabayashi H; Takahashi W; Yazaki Y; Watanabe N; Imamura H; Kubo K
    Pacing Clin Electrophysiol; 2001 Aug; 24(8 Pt 1):1293-4. PubMed ID: 11523620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment of electrical storm with oral quinidine in Brugada syndrome.
    Bettiol K; Gianfranchi L; Scarfò S; Pacchioni F; Pedaci M; Alboni P
    Ital Heart J; 2005 Jul; 6(7):601-2. PubMed ID: 16274024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful radiofrequency catheter ablation for electrical storm of ventricular fibrillation in a patient with Brugada syndrome.
    Nakagawa E; Takagi M; Tatsumi H; Yoshiyama M
    Circ J; 2008 Jun; 72(6):1025-9. PubMed ID: 18503235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive impact of the inducibility of ventricular fibrillation in patients with Brugada-type ECG.
    Imaki R; Niwano S; Fukaya H; Sasaki S; Yuge M; Hirasawa S; Sato D; Sasaki T; Moriguchi M; Izumi T
    Int Heart J; 2006 Mar; 47(2):229-36. PubMed ID: 16607050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cilostazol attenuates ventricular arrhythmia induction and improves defibrillation efficacy in swine.
    Kanlop N; Shinlapawittayatorn K; Sungnoon R; Weerateerangkul P; Chattipakorn S; Chattipakorn N
    Can J Physiol Pharmacol; 2010 Apr; 88(4):422-8. PubMed ID: 20555410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrophysiologic characteristics and implications of induced ventricular fibrillation in symptomatic patients with Brugada syndrome.
    Kanda M; Shimizu W; Matsuo K; Nagaya N; Taguchi A; Suyama K; Kurita T; Aihara N; Kamakura S
    J Am Coll Cardiol; 2002 Jun; 39(11):1799-805. PubMed ID: 12039494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of low-dose quinidine on ventricular tachyarrhythmias in patients with Brugada syndrome: low-dose quinidine therapy as an adjunctive treatment.
    Mizusawa Y; Sakurada H; Nishizaki M; Hiraoka M
    J Cardiovasc Pharmacol; 2006 Mar; 47(3):359-64. PubMed ID: 16633076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mode of onset of ventricular fibrillation in patients with Brugada syndrome detected by implantable cardioverter defibrillator therapy.
    Kakishita M; Kurita T; Matsuo K; Taguchi A; Suyama K; Shimizu W; Aihara N; Kamakura S; Yamamoto F; Kobayashi J; Kosakai Y; Ohe T
    J Am Coll Cardiol; 2000 Nov; 36(5):1646-53. PubMed ID: 11079671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronotropic effects of cilostazol, a new antithrombotic agent, in patients with bradyarrhythmias.
    Atarashi H; Endoh Y; Saitoh H; Kishida H; Hayakawa H
    J Cardiovasc Pharmacol; 1998 Apr; 31(4):534-9. PubMed ID: 9554801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term pharmacological therapy of Brugada syndrome: is J-wave attenuation a marker of drug efficacy?
    Hasegawa K; Ashihara T; Kimura H; Jo H; Itoh H; Yamamoto T; Aizawa Y; Horie M
    Intern Med; 2014; 53(14):1523-6. PubMed ID: 25030565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ST-segment elevation and ventricular fibrillation without coronary spasm by intracoronary injection of acetylcholine and/or ergonovine maleate in patients with Brugada syndrome.
    Noda T; Shimizu W; Taguchi A; Satomi K; Suyama K; Kurita T; Aihara N; Kamakura S
    J Am Coll Cardiol; 2002 Nov; 40(10):1841-7. PubMed ID: 12446069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Brugada syndrome].
    Fischer S; Reinhold S; Kettner W
    Med Klin (Munich); 2001 Aug; 96(8):485-8. PubMed ID: 11560050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of electrophysiologic-guided therapy with Class IA antiarrhythmic drugs on the long-term outcome of patients with idiopathic ventricular fibrillation with or without the Brugada syndrome.
    Belhassen B; Viskin S; Fish R; Glick A; Setbon I; Eldar M
    J Cardiovasc Electrophysiol; 1999 Oct; 10(10):1301-12. PubMed ID: 10515552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Similarities between Brugada syndrome and ischemia-induced ST-segment elevation. Clinical correlation and synergy.
    Chinushi M; Furushima H; Tanabe Y; Washizuka T; Aizawaz Y
    J Electrocardiol; 2005 Oct; 38(4 Suppl):18-21. PubMed ID: 16226069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anesthetic management for patients with Brugada syndrome].
    Kawaguchi Y; Kushikata T; Hashiba E; Kitayama M; Yoshida H; Ishihara H; Matsuki A; Hirota K
    Masui; 2006 Feb; 55(2):142-9. PubMed ID: 16491889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of ventricular fibrillation in Brugada syndrome by site-specific right ventricular premature depolarization.
    Chinushi M; Washizuka T; Chinushi Y; Higuchi K; Toida T; Aizawa Y
    Pacing Clin Electrophysiol; 2002 Nov; 25(11):1649-51. PubMed ID: 12494627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The circadian pattern of the development of ventricular fibrillation in patients with Brugada syndrome.
    Matsuo K; Kurita T; Inagaki M; Kakishita M; Aihara N; Shimizu W; Taguchi A; Suyama K; Kamakura S; Shimomura K
    Eur Heart J; 1999 Mar; 20(6):465-70. PubMed ID: 10213350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.